Ophthalmology PACS Market To Reach $248.6 Million By 2030

Ophthalmology PACS Market Growth & Trends

The global ophthalmology PACS market size is expected to reach USD 248.6 million by 2030, expanding at a CAGR of 7.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. Moreover, rising prevalence of eye diseases, such as cataract, glaucoma, age-related macular degeneration, and diabetic retinopathy, is expected to fuel demand for ophthalmology PACS in near future. The Department of Ophthalmology of National University of Singapore conducted a study in collaboration with National University Health System, Singapore and South Central Asia. According to this study, the number of glaucoma cases diagnosed in 2013 was 17.06 million, which is anticipated to reach around 32.9 million by 2040.

Product development, geographical expansion and M&A are some sustainability strategies adopted by major companies in this market. For instance, in August 2017, Carl Zeiss Meditec Inc., acquired Veracity Innovations, LLC, a U.S.-based medical software company that delivers cloud-based platforms to maximize clinical performance and work efficiency. These platforms help ophthalmologists in delivering personalized technology-enabled care to their patients. The acquisition is intended to expand the former company’s eye care-based digital solutions portfolio. The company is also focusing on expanding the business in Asia Pacific owing to larger patient pool in this region.

 Request a free sample copy or view report summary: Ophthalmology PACS Market Report

Ophthalmology PACS Market Report Highlights

• Increasing cases of ophthalmic diseases, lack of skilled ophthalmologists, and growing usage of teleophthalmology solutions in developed countries are the factors driving the market

• Cloud-based PACS is anticipated to register lucrative growth during the forecast period owing to features, such as interoperability and mutual performance, privacy and security, reduced errors, and improved quality

• North America held the major share of the market in 2022 due to increased ophthalmic disease burden and healthcare expenditure by public and private firms in this region

• Asia-Pacific is anticipated to register the highest CAGR during forecast period due to rising prevalence of glaucoma coupled with high demand for an effective diagnostic solution

• Carl Zeiss Meditec AG; Topcon Corp.; Merge Healthcare, Inc. are the major companies in the global ophthalmology PACS market

• Most of these companies are focusing on technological advancements, M&A, and R&D as part of their business expansion strategies

Ophthalmology PACS Market Segmentation

Grand View Research has segmented the global ophthalmology PACS market based on type, mode of action, end-use, and region:

Ophthalmology PACS Type Outlook (Revenue, USD Million, 2018 - 2030)

• Standalone PACS

• Integrated PACS

Ophthalmology PACS Mode of Action Outlook (Revenue, USD Million, 2018 - 2030)

• On-premises System

• Cloud-based System

Ophthalmology PACS End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital

• Specialty Clinics

• Others

Ophthalmology PACS Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Ophthalmology PACS Market

• Carl Zeiss Meditec AG

• Topcon Corporation

• Heidelberg Engineering GmbH

• Sonomed Escalon

• Visbion

• EyePACS, LLC

• VersaSuite

• Merge Healthcare Inc (IBM Watson Health)

• ScImage, Inc.